About Dallas McMillan

Dallas McMillan is founder and President of Rhizo Sciences and leads the international hemp and cannabis activities. Recognised as a leading authority in production of truly medical grade cannabis, Dallas leads a team of agricultural, medical and pharmaceutical specialists with a passion for cannabis and hemp and the impact they can make on human health, the environment, and economies. Key to Rhizo Sciences' success in the industry has been an emphasis on leveraging proven technology, personnel and processes from traditional industries while honoring the unique value and characteristics of the cannabis plant and those who have worked tirelessly to bring it into the mainstream. Connect with Dallas on Linkedin or Email.

CBD Isolate Benefits

By |2019-03-12T22:57:19+00:00Mar,19 8|Categories: Medical Cannabis|

Benefits of CBD Isolate - Health, Legal and Practical CBD Isolate benefits many serious health conditions, and is the subject of hundreds of clinical trials.  It also has many practical benefits as a pharmaceutical drug ingredient, a botanical extract, a manufacturing ingredient and article of commerce, but may not match the therapeutic benefits of other hemp [...]

CBD Isolate Drug Epidiolex Approved by FDA

By |2019-03-10T03:01:17+00:00Mar,19 8|Categories: CBD|Tags: , , , , , , , , , , |

Epidiolex, a new pharmaceutical drug containing CBD Isolate opens up a new era of cannabinoid medicine and cannabis reform. CBD Isolate Anti-Epilepsy Drug Epidiolex Approved by FDA On June 25, 2018, the United States Food & Drug Administration (FDA) approved EPIDIOLEX® - a CBD isolate-based oral solution for the treatment of seizures associated with two severe epilepsy syndromes - Lennox-Gastaut [...]

Hemp Biomass Products

By |2019-03-12T11:56:08+00:00Oct,18 10|Categories: CBD, Hemp|Tags: , , , , , , , , , , |

Hemp Biomass Products Industrial Hemp is an incredibly versatile plant renowned for it's long history of human use to produce wide range of products - from medicine (CBD) to food (oil and seeds) to fibre (stem) and much more. Hemp biomass can also be used to produce energy by combustion, fermentation and other processes. Hemp plants [...]

Pharmaceutical Grade Cannabinoids for Clinical Trials

By |2018-10-06T08:43:36+00:00Oct,18 6|Categories: Medical Cannabis|Tags: , , , , , , , , , |

Why Pharmaceutical Grade Cannabinoids Are Needed for Clinical Trials Recently, Tilray made big news announcing that they would be importing Canadian cannabis into the USA for clinical trials. This ruffled some feathers in the US cannabis industry, who operate under state legal programs while the US Federal law insists that cannabis is a highly dangerous and [...]

CBD Oil vs Hemp Oil vs Hemp Seed Oil – What’s the difference

By |2018-09-29T06:22:13+00:00Sep,18 29|Categories: Medical Cannabis|Tags: , , , , , , |

CBD Oil vs Hemp Oil vs Hemp Seed Oil - What's the difference? CBD Oil, Hemp Oil and Hemp Seed Oil are related products which can be produced from the Hemp plan, Cannabis Sativa. Consumers and health professionals often get confused by the differences between the different products hemp oil products. Hemp Seed Oil Hemp Seed Oil [...]

Pharma Grade CBD Products to be Rescheduled

By |2018-09-29T00:06:18+00:00Sep,18 29|Categories: Medical Cannabis|Tags: , , , , , , , , |

Pharma Grade CBD Products to be Rescheduled to Schedule V Pharma Grade CBD Products such as Epidiolex will be Schedule V - comparable to codeine-containing cough syrups - indicating a low potential for abuse and effectiveness as a therapeutic drug. The Drug Enforcement Agency published a notification on the FDA CBD rescheduling in the Federal Register. "With [...]

CBD Isolate Drugs Rescheduled by the FDA

By |2018-09-28T06:03:43+00:00Sep,18 28|Categories: CBD|Tags: , , , , , , , , , |

CBD Isolate Drugs Rescheduled by the FDA CBD isolate based drug Epidolex has been removed from Schedule I and placed in Schedule V which will make access to the drug much simpler for patients who can afford it. The rescheduling is a major breakthrough in the medical cannabis and hemp CBD industry because it finally recognises [...]

Coca Cola’s CBD Move and what it means for the Cannabis Industry

By |2018-09-24T00:06:10+00:00Sep,18 23|Categories: CBD|Tags: , , , , , , , , , |

Will Coca Cola Become an Infused Beverage Leader? Coca-Cola is looking at Cannabis derived ingredient - CBD (Cannabidiol) as a possible ingredient in health drinks. While this may seem strange at first we should remember that Coca Cola started out as a tonic containing botanical extracts including cocaine. Coca-Cola is in talks with a major Canadian cannabis [...]

Hemp industry turns to Pharma tech to meet growing demand for Cannabidiol

By |2019-02-26T00:21:41+00:00May,18 11|Categories: Medical Cannabis|Tags: , , , , , |

Hemp industry turns to Pharma tech to meet growing demand for Cannabidiol Rhizo Sciences offers large scale CO2 extraction systems to process hemp at industrial scale Seattle, May 10, 2018   The hemp industry is undergoing a renaissance due to an explosion of interest in Cannabidiol, (aka CBD) but it’s struggling to keep up with demand [...]

African Medical Cannabis Exported to Canada in Historic First for Industry

By |2018-05-04T04:07:38+00:00May,18 4|Categories: International Cannabis|

Medical Cannabis: Out of Africa Africa is one of the homelands of modern medical cannabis. Many of the most prominent medical cannabis genetics have African Ancestry, and names such as Durban Poison (South African), Malawi Gold, and Moroccan Hash are touchstones for cannabis geneticists. A treasure trove of landrace strains are still preserved around the continent [...]